EUVIMEDEUVIMED entdecken
Crossref

The Disparities in Myasthenia Gravis Clinical Trial Enrollment in the United States and Canada

Jose A Sanchez iD, Danelvis Paredes iD, Jeffrey T Guptill iD, Stephen L Aita iD, James F Howard iD

Muscle & Nerve · 2026-02 · 73 (2) · 313-318

DOI: 10.1002/mus.70125 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Muscle & Nerve, online erschienen am 24.12.2025. Verfasst von Jose A Sanchez und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, University of South Alabama, Mobile, Alabama, USA. Hauptthemen laut MEDLINE: Myasthenia Gravis, Clinical Trials as Topic, Patient Selection, Healthcare Disparities. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction/Aims The demographic and geographic representation of participants in myasthenia gravis (MG) trials has yet to be systematically reviewed. The goal of this study was to explore potential disparities in MG interventional clinical trial enrollment.

Methods

We included completed interventional clinical trials from January 2002 to December 2021 that enrolled participants with MG within the United States and Canada. Twenty‐eight trials meeting these criteria were identified at Clinicaltrials.gov , and 16 trials contributed data. Study sponsors provided data for age, sex/gender, race, ethnicity, and state/province of site enrollment.

Results

Pooled data showed the following participant ethno‐racial composition across trials: White = 79.9%, Black = 11.9%, Asian = 3.3%, Native American = 1.2%, “Other” race = 3.7%; 10.5% of participants identified as Hispanic ethnicity. Male participation was approximately 53%. Average participant age was 55.0 ± 17.0 years. The three highest enrolling US states were Texas, California, and Florida, and the highest enrolling Canadian province was Ontario. There was no enrollment in several Upper Midwest, Northern Rocky Mountain, and Southern US states. Total enrollment among White, Black, and Native American participants was proportional to the US population, whereas Hispanic and Asian participants were under‐enrolled.

Discussion

The geographic distribution of enrollment suggests a possible concern that many patients do not have convenient access to trial centers. Strategies are needed to facilitate greater clinical trial participation among underrepresented and underserved communities that will improve generalization of study results to the overall MG population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myasthenia GravisClinical Trials as TopicPatient SelectionHealthcare DisparitiesHumansUnited StatesCanadaMaleFemaleMiddle AgedAgedAdultEthnicity

Stichwörter der Autor:innen

clinical disparitiesclinical trial enrollmentgeographic accessibilitymyasthenia gravis (MG)

Autor:innen und Institutionen

  • Department of Neurology, University of South Alabama, Mobile, Alabama, USA.
  • Department of Neurology, Duke University Medical Center, Durham, North Carolina, USA.
  • Argenx, Boston, Massachusetts, USA.
  • Department of Neurology, The University of North Carolina, Chapel Hill, North Carolina, USA.

ORCID-Profile: Jose A Sanchez, Danelvis Paredes, Jeffrey T Guptill, Stephen L Aita, James F Howard

Zitieren

APA

Sanchez, J. A., Paredes, D., Guptill, J. T., Aita, S. L., & Howard, J. F. (2026). The Disparities in Myasthenia Gravis Clinical Trial Enrollment in the United States and Canada. Muscle & Nerve, 73(2), 313-318. https://doi.org/10.1002/mus.70125

Vancouver

Sanchez JA, Paredes D, Guptill JT, Aita SL, Howard JF. The Disparities in Myasthenia Gravis Clinical Trial Enrollment in the United States and Canada. Muscle & Nerve. 2026;73(2):313-318. doi:10.1002/mus.70125

BibTeX
@article{Sanchez2026,
  author = {Sanchez, Jose A and Paredes, Danelvis and Guptill, Jeffrey T and Aita, Stephen L and Howard, James F},
  title = {The Disparities in Myasthenia Gravis Clinical Trial Enrollment in the United States and Canada},
  journal = {Muscle & Nerve},
  year = {2026},
  volume = {73},
  number = {2},
  pages = {313--318},
  doi = {10.1002/mus.70125}
}
Kostenlos starten →